Clinical Trials Browser

Phase 1/2 × Withdrawn × Gliosarcoma × Clear all

NCT02521090 2016-02-15

EGFRBi-Armed Autologous T Cells in Treating Patients With Recurrent or Refractory Glioblastoma

Phase 1/2 Withdrawn

Brain Neoplasms, Gliosarcoma

NCT00021307 2013-07-11

Temozolomide Plus Carboplatin in Treating Patients With Recurrent Glioblastoma Multiforme

Phase 1/2 Withdrawn

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma